Mirsky Nicholas A, Ehlen Quinn T, Greenfield Jason A, Antonietti Michael, Slavin Blaire V, Nayak Vasudev Vivekanand, Pelaez Daniel, Tse David T, Witek Lukasz, Daunert Sylvia, Coelho Paulo G
University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Bioengineering (Basel). 2024 Jul 31;11(8):777. doi: 10.3390/bioengineering11080777.
Since three-dimensional (3D) bioprinting has emerged, it has continuously to evolved as a revolutionary technology in surgery, offering new paradigms for reconstructive and regenerative medical applications. This review highlights the integration of 3D printing, specifically bioprinting, across several surgical disciplines over the last five years. The methods employed encompass a review of recent literature focusing on innovations and applications of 3D-bioprinted tissues and/or organs. The findings reveal significant advances in the creation of complex, customized, multi-tissue constructs that mimic natural tissue characteristics, which are crucial for surgical interventions and patient-specific treatments. Despite the technological advances, the paper introduces and discusses several challenges that remain, such as the vascularization of bioprinted tissues, integration with the host tissue, and the long-term viability of bioprinted organs. The review concludes that while 3D bioprinting holds substantial promise for transforming surgical practices and enhancing patient outcomes, ongoing research, development, and a clear regulatory framework are essential to fully realize potential future clinical applications.
自从三维(3D)生物打印技术出现以来,它作为外科手术中的一项革命性技术不断发展,为重建和再生医学应用提供了新的范例。这篇综述重点介绍了过去五年中3D打印技术,特别是生物打印技术在多个外科领域的整合情况。所采用的方法包括对近期文献的回顾,这些文献聚焦于3D生物打印组织和/或器官的创新与应用。研究结果显示,在创建模仿天然组织特征的复杂、定制化多组织构建体方面取得了重大进展,这对于手术干预和针对患者的治疗至关重要。尽管技术取得了进步,但本文介绍并讨论了仍然存在的若干挑战,例如生物打印组织的血管化、与宿主组织的整合以及生物打印器官的长期存活能力。该综述得出结论,虽然3D生物打印在改变手术实践和改善患者治疗效果方面具有巨大潜力,但持续的研究、开发以及明确的监管框架对于充分实现未来潜在的临床应用至关重要。